These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 2402946)
1. [The combination of psoriasis with different types of lipoproteinemias. 2. The characteristics of the dyslipoproteinemias caused by disorders in triacylglyceride transport in psoriasis]. Keshileva ZB; Kosukhin AB; Polevaia LG Vestn Dermatol Venerol; 1990; (5):7-11. PubMed ID: 2402946 [TBL] [Abstract][Full Text] [Related]
2. [Different types of blood lipoproteins in psoriasis patients. 1. The relationship of dyslipoproteinemias due to disordered cholesterol transport and the course of psoriasis]. Keshileva ZB; Kosukhin AB; Polevaia LG; Nusupova ZhA Vestn Dermatol Venerol; 1990; (2):7-11. PubMed ID: 2343674 [TBL] [Abstract][Full Text] [Related]
3. [Apolipoprotein E and activity of cholesterol esters transport in type IIA and IIB hyperlipoproteinemia]. Tvorogova MG; Rozhkova TA; Semenova OA; Lupanov VP; Nuraliev EIu ; Kukharchuk VV; Titov VN Ter Arkh; 1997; 69(12):30-3. PubMed ID: 9503530 [TBL] [Abstract][Full Text] [Related]
4. Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations. Bonora V; Calalabuig RJ; Caviola E; Soler J; Pueyo JM; Micaló T; Cano RP Clin Ther; 1981; 4(3):192-200. PubMed ID: 7030489 [TBL] [Abstract][Full Text] [Related]
5. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis]. Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981 [TBL] [Abstract][Full Text] [Related]
6. Reversible increase of the apo CII/apo CIII-1 ratio in the very low density lipoproteins after procetofen treatment in hypertriglyceridemic patients. Franceschini G; Sirtori M; Gianfranceschi G; Frosi T; Montanari G; Sirtori CR Artery; 1985; 12(6):363-81. PubMed ID: 4051756 [TBL] [Abstract][Full Text] [Related]
7. [Fatty acid metabolism in primary hyperlipoproteinemia (HLP) (author's transl)]. Reuter W Dtsch Z Verdau Stoffwechselkr; 1979; 39(3):124-9. PubMed ID: 520271 [TBL] [Abstract][Full Text] [Related]
8. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV. Lopez Rodriguez J; Martorell J Clin Ther; 1980; 3(4):234-41. PubMed ID: 7273061 [TBL] [Abstract][Full Text] [Related]
9. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia. Saku K; Sasaki J; Arakawa K Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372 [TBL] [Abstract][Full Text] [Related]
10. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks. Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424 [TBL] [Abstract][Full Text] [Related]
11. [Cholesterol and triglyceride plasma levels in patients with primary hyperlipoproteinemia. Decline after short-term i.v. glucagon administration]. Andĕl M; Brodan V; Kucerová L; Grafnetter D; Kuhn E; Veselková A Cas Lek Cesk; 1980 May; 119(22):616-21. PubMed ID: 7427980 [No Abstract] [Full Text] [Related]
12. [Lipid metabolism disorders and soft palate lipid changes in myocardial infarct]. Dubejko J; Markiewicz M; Michałowski R; Kutarski A Pol Tyg Lek; 1980 Aug; 35(32):1217-9. PubMed ID: 7433204 [No Abstract] [Full Text] [Related]
13. [Indications for and the therapeutic action of hypolipidemic agents in patients with hyperlipoproteinemias]. Goranov I; Naumova R; Kerekovska M; Balabanski L Vutr Boles; 1987; 26(1):96-101. PubMed ID: 3590738 [TBL] [Abstract][Full Text] [Related]
14. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V]. Hutt V; Wechsler JG; Klör HU; Ditschuneit H Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558 [TBL] [Abstract][Full Text] [Related]
15. [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate]. Schiffl H; Weidmann P; Fragiacomo C; Noseda G; Bachmann C Schweiz Med Wochenschr; 1985 Jun; 115(26):907-11. PubMed ID: 3927481 [TBL] [Abstract][Full Text] [Related]
16. [Blood plasma prostaglandins and their role in disorders of lipid metabolism in ischemic heart disease caused by coronary arteriosclerosis]. Bochkareva EV; Zykova VP; Lobova NM; Polesskiĭ VA; Gadzhanova SI Ter Arkh; 1980; 52(5):18-22. PubMed ID: 7404361 [No Abstract] [Full Text] [Related]
17. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity. Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423 [TBL] [Abstract][Full Text] [Related]